(S)-(-)-HA-966, a γ-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitization

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 712-721

  Morrow, Bret A ^a   Lee, Edward J K ^a   Taylor, Jane R ^a   Elsworth, John D ^a   Nye, Heather E ^a   Roth, Robert H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 HYDROXYBUTYRIC ACID; BACLOFEN; COCAINE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEFECATION; DOPAMINE METABOLISM; DOSE RESPONSE; DRUG MECHANISM; FEAR; HABITUATION; IMMOBILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC SYSTEM; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEDATION; STRESS; WEIGHT GAIN;

ANIMALS; COCAINE; CONDITIONING (PSYCHOLOGY); DOPAMINE; FEAR; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RESTRAINT, PHYSICAL; STEREOISOMERISM; STRESS, PSYCHOLOGICAL;

EID: 0030730002     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. BENAVISEA, J., RUMIGNY, J. F. BOURGUIGNON, J. J., CASH, C., WERMUTH, C. G., MANDEL, P., VINCENDON, G. AND MAITRE, M.: High affinity binding site for γ-hydroxybutyric acid in rat brain. Life Sci. 30: 953-961, 1982.
2. B receptor. J. Pharmacol. Exp. Ther. 265: 765-770, 1993.
3. BONTA, I. L., DE VOS, C. J., HILLEN, F. C., NOACH, E. L. AND SIM, A. W.: 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966): A new GABA-like compound with potential use in extrapyramidal diseases. Br. J. Pharmacol. 43: 514-535, 1971.
4. BRISTOW, L. J., HUTSON, P. H., THORN, L. AND TRICKLEBANK, M. D.: The glycine/NMDA receptor antagonist, (+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencycidine and dizocilpine (MK-801) in rodents. Br. J. Pharmacol. 108: 1156-1163, 1993.
5. BROXTERMAN H. J., NOACH, E. L., VAN VALKENBURG, C. F. M. AND WIJLING, A.: Cross-tolerance of dopamine metabolism to baclofen, γ-butyrolactone and HA-966 in the striatum and olfactory tubercle of the rat. Life Sci. 28: 973-981, 1981.
6. COOLS, A. R., DE BELTRAN, K. K., PRINSSEN, E. P. M. AND KOSHIKAWA, N.: Differential role of core and shell of the nucleus accumbens in jaw movements of rats. Neurosci. Res. Commun. 13: 55-61, 1993.
7. DAVIES, J. AND WATKINS, J. C.: Is 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) a selective excitatory amino acid antagonist? Nature New Biol. 238: 61-63, 1972.
8. DEUTCH, A. Y. AND CAMERON, D. S.: Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience 48: 49-57, 1992.
9. DOHERTY, J. D., HATTOX, S. E., SNEAD, O. C. AND ROTH, R. H.: Identification of endogenous γ-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain. J. Pharmacol. Exp. Ther. 207: 130-139, 1978.
10. DOWNS, A. W. AND EDDY, N. B.: The effect of repeated doses of cocaine on the rat. J. Pharmacol. Exp. Ther. 46: 199-202, 1932.
11. ELSWORTH, J. D., DEUTCH, A. Y., REDMOND, D. E. JR., TAYLOR, J. R., SLADEK, J. R. JR. AND ROTH, R. H.: (1989) Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydroppyridine-treated primates: Biochemical changes in striatal regions. Neuroscience 33: 321-333.
12. ENGBERG, G. AND NISSBRANDT, H.: γ-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 348: 491-497, 1993.
13. FOSTER, A. C. AND KEMP, J. A.: HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site. J. Neurosci. 9: 2191-2196, 1989.
14. GOLDSTEIN, L. E., RASMUSSON, A. M., BUNNEY, B. S. AND ROTH, R. H.: The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: A behavioral, neuroendocrine and neurochemical study in the rat. J. Neurosci. 14: 4937-4950, 1994.
15. HEIMER, L., ZAHM, D. S., CHURCHHILL, L., KALIVAS, P. W. AND WOHLTMANN, C.: Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41: 89-125, 1991.
16. 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain. Nature 290: 149-152, 1981.
17. HORGER, B. A., ELSWORTH, J. D. AND ROTH, R. H.: Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine agonist FG-7142. J. Neurochem. 65: 770-774, 1995.
18. HUTSON, P. H., BRISTOW, L. J., THORN, L. AND TRICKLEBANK, M. D.: R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br. J. Pharmacol. 103: 2037-2044, 1991.
19. KALIVAS, P. W. AND DUFFY, P.: Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res. 675: 325-328, 1995.
20. KALIVAS, P. W., DUFFY, P., DUMAR, L. A. AND SKINNER, C.: Neurochemical and behavioral effects of acute and daily cocaine. J. Pharmacol. Exp. Ther. 245: 485-492, 1988.
21. KALIVAS, P. W. AND STEWART J.: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain. Res. Rev. 16: 223-244, 1991.
22. KARLER, R. CHAUDHRY, I. A., CALDER, L. D. AND TURKANIS, S. A.: Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537: 76-82, 1990.
23. MAITRE, M., RUMIGNY, J. F., BENAVIDES, J., BOURGUIGNON, J. J., WERMUTH, C. G., CASH, C., MANDEL, P.: High affinity binding site of gamma-hydroxybutyric acid in rat brain. Adv. Biochem. Psychopharmacol. 37: 441-453, 1983.
24. MCMILLEN, B. D., WILLIAMS, H. L., LEHMANN, H. AND SHEPARD, P. D.: On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs: Zoxazolamine and HA-966. J. Neural Transm. 89: 11-25, 1992.
25. MORROW, B. A., CLARK, W. A. AND ROTH, R. H.: Regulation of mesocorticolimbic lopamine systems by a glycine/NMDA receptor antagonist. Eur. J. Pharmacol. 238: 255-262, 1993.
26. MORROW, B. A., TAYLOR, J. R. AND ROTH, R. H.: R-(+)-HA-966, an antagonist for he glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures. Brain Res. 673: 165-169, 1995a.
27. MORROW, B. A., TAYLOR, J. R. AND ROTH, R. H.: Prior exposure to cocaine diminishes behavioral and biochemical responses to aversive conditioning: reversal by glycine/N-methyl-d-aspartate antagonist co-treatment. Neuroscience 69: 233-240, 1995b.
28. MOTOHASHI, N., IKAWA, K. AND KARIYA, T.: GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine: GABA hypothesis of affective disorders? Eur. J. Pharmacol. 166: 95-99, 1989.
29. NOWYCKY, M. C. AND ROTH, R. H.: Reversible lesion of central dopamine neurons with 1-hydroxy-3-amino-pyrrolidone-2. Am. Soc. Neurochem. Abstr. 8: 72, 99., 1977.
30. POST, R. M. AND CONTEL, N. R.: Human and animal studies of cocaine: Implications for development of behavioral pathology. In Stimulants: Neurochemical. Behavioral and Clinical Perspectives, ed. by I. Creese, pp. 169-203, Raven Press, New York, 1983.
31. PULLAN, L. M., BRITT, M., CHAPDELAINE, M. J., KEITH, R. A., LAMONTE, D., MANOANO, T. J., PATEL, J., POWEL, R. J., STUMPO, R. J., WARWICK, P. J., ZINK AND, W. C. AND SALAMA, A. I.: Stereoselectivity for the (R)-enantiomer of HA-966 (1-hydroxy-3-aminopyrrolidone-2) at the glycine site of the N-methyl-d-aspartate receptor complex. J. Neurochem. 55: 1346-1351, 1990.
32. ROTH, R. H., NOWYCKY, M. C., WALTERS, J. R. AND MOREGENROTH, V. H., III: γ-Hydroxybutyrate: effects on nonstriatal dopaminergic neurons. In Advances in Biochemical Psychopharmacology, Vol. 16, ed. by E. Costa and G. L. Gessa, pp. 483-488. Raven Press, New York, 1977.
33. ROTH, R. H., TAM, S. Y., YANG, J. X., DEUTCH, A. Y.: Stress and the mesocorticolimbic dopamine system. Ann. N. Y. Acad. Sci. 537: 138-147, 1988.
34. ROTH, R. H., WALTERS, J. R. AND AGHAJANIAN, G. K.: Effect of impulse flow on the release and synthesis of dopamine in the striatum. In Frontiers in Catecholamine Research, ed. by S. H. Snyder and E. Isdin, pp. 567-574, Pergamon, Oxford, 1973.
35. SHEPARD, P. D., CONNELLY, S. T. AND GROBASKI, K. C.: Electrophysiological effects of (-)-HA-966: Evidence for an interaction with GABAB receptors. Soc. Neurosci. Abstr. 19: 1372, 1993.
36. SHEPARD, P. D., CONNELLY, S. T., LEHMANN, H. AND GROBASKI, K. C.: Effects of the enantiomers of (+)-HA-966 on dopamine neurons: an electrophysiological study of a chiral molecule. Eur. J. Pharmacol. 285: 79-88, 1995.
37. SHEPARD, P. D. AND LEHMANN, H.: (±)-1-Hydroxy-3-aminopyrrolidone (HA-966) inhibits the activity of substantia nigra dopamine neurons through a non-N-methyl-d-aspartate receptor-mediated mechanism. J. Pharmacol. Exp. Ther. 261: 387-394, 1992.
38. SINGH, L., DONALD, A. E., FOSTER, A. C., HUTSON, P. H., IVERSEN, L. L., IVERSEN, S. D., KEMP, J. A., LEESON, P. D., MARSHALL, G. R., OLES, R. J., PRIESTLEY, T., THORN, L., TRICKLEBANK, M. D., VASS, C. A. AND WILLIAMS, B. J.: Enantiomers of HA-966 (3-amino-1-hydroxypyirolid-2-one) exhibit distinct central nervous system effects: (+)HA-966 is a selective glycine/N-methyl-d-aspartate receptor antagonist, but (-)HA-966 is a potent γ-butyrolactone-like sedative. Proc. Natl. Acad. Sci. USA 87: 347-351, 1990.
39. TUNNICLIFF, G.: Significance of κ-hydroxybutyric acid in the brain. Gen. Pharmacol. 23: 1027-1034, 1992.
40. B antagonist CGP 35348 antagonizes the effects of baclofen, γ-butyrolactone and HA-966 on rat striatal dopamine synthesis. Naunyn-Schmiedeberg's Arch Pharmacol. 343: 173-178, 1991.
41. WISE, R. A. AND LEEB, K.: Psychomotor-stimulant sensitization: A unitary phenomenon? Behav. Pharmacol. 4: 339-349, 1993.
42. WOLF, M. E. AND JEZIORSKI, M.: Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613: 291-294, 1993.
43. ZAHM, D. S.: Compartments in rat dorsal and ventral striatum revealed following injection of 6-hydroxydopamine into the ventral mesencephalon. Brain Res. 552: 164-169, 1991.
44. ZAHM, D. S. AND HEIMER, L.: Two transpallidal pathways originating in the rat nucleus accumbens. J. Comp. Neurol. 302: 437-446, 1990.